Amgen - AMGN EV/Sales Multiple

Public company logo of Amgen (AMGN)

Complex cold chain transportation increases delivery costs, while patent protection and M&A deals retain customers despite pricing pressure from US law. This Enterprise Value to Revenue chart visualizes these cycles, where 7136.84 serves as the final level marker. The result secures Amgen Inc. (AMGN) the status of a biotech pioneer with high margins driven by unique protein developments.

Amgen Corporation (AMGN) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

AMGN (Amgen Inc.): analytical breakdowns and indicator data

- stock value and consensus price forecast:
Fundamental valuation:Amgen Inc. AMGN
Core merchandise of Amgen Inc

This indicator determines the Enterprise Value of the entire business relative to annual sales, excluding the impact of capital structure. By analyzing the EV/Revenue multiple on the GURU.Markets platform, an investor assesses the market premium paid for every dollar of revenue. This metric's trend is sensitive to M&A transaction costs, which is critical for Amgen Inc. (AMGN) during aggressive acquisitions of biotech startups and the expansion of its biosimilars portfolio.